Accessibility Menu
 
Cannabis Strategic Ventures logo

Cannabis Strategic Ventures

(OTC) NUGS

Current Price$0.00
Market Cap$405,000
Since IPO (2005)-84%
5 Year-99%
1 Year+99,900%
1 Month+0%

Cannabis Strategic Ventures Financials at a Glance

Market Cap

$405,000

Revenue (TTM)

$4.79M

Net Income (TTM)

$9.87M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

73.67 (High)

Price

$0.00

Volume

1

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

NUGS News

No articles available.

NUGS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabis Strategic Ventures

Industry

Pharmaceuticals

CEO

Simon Yu, MBA

Headquarters

Los Angeles, CA 90014, US

NUGS Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-73%

Net Income Margin

-87%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-77%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$405.00K

Shares Outstanding

405.00M

Volume

1

Short Interest

0.00%

Avg. Volume

80.08K

Financials (TTM)

Gross Profit

$921.73K

Operating Income

$7.22M

EBITDA

$5.70M

Operating Cash Flow

$1.43M

Capital Expenditure

$4.00

Free Cash Flow

$1.43M

Cash & ST Invst.

$25.19K

Total Debt

$13.85M

Cannabis Strategic Ventures Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2022YOY CHG

Revenue

$57.88K

-98.9%

Gross Profit

$54.61K

-103.6%

Gross Margin

-94.36%

N/A

Market Cap

$405.00K

N/A

Market Cap/Employee

$13.50K

N/A

Employees

30

N/A

Net Income

$1.80M

-239.9%

EBITDA

$1.66M

-1082.4%

Quarterly Fundamentals

Name
Q2 2022YOY CHG

Net Cash

$13.55M

+36.6%

Accounts Receivable

$24.11K

-95.9%

Inventory

$2.32M

+4.2%

Long Term Debt

$1.76M

-63.0%

Short Term Debt

$11.81M

-30.2%

Return on Assets

-76.96%

N/A

Return on Invested Capital

1.18%

N/A

Free Cash Flow

$2.33M

-367.7%

Operating Cash Flow

$2.33M

-367.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTLFPetlife Pharmaceuticals, Inc.
$0.00+0.00%
HSMDHealthcare Solutions Management Group, Inc.
$0.00+0.00%
AOLSAeolus Pharmaceuticals, Inc.
$0.00+0.00%
HCANFHalo Collective Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About NUGS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.